Caris Life Sciences Inc.
Caris Life Sciences Inc. (CAI): 3 pipeline candidates · ~29 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
29.0 months
D/E 0.96 · 0% dilution
Lead: Approved
3 candidates
N/A
1 buy · 0 sells (180d)
A transparent, data-derived signal for Caris Life Sciences Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$5.1B
Cash
$819.9M
Quarterly Burn
$91.0M
Runway
29.0 mo
Revenue
$216.2M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| caris assure | Preclinical |
| caris detect | Preclinical |
| mi cancer seek | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
198
Total value held
$1.95B
| Holder | Shares | Value |
|---|---|---|
| fmr llc | 30,785,585 | $550.4M |
| coatue management llc | 9,819,992 | $175.6M |
| braidwell lp | 8,009,447 | $143.2M |
| vanguard capital management llc | 6,658,042 | $119.0M |
| blackrock, inc. | 4,857,112 | $86.8M |
| vanguard portfolio management llc | 3,758,462 | $67.2M |
| neuberger berman group llc | 3,590,586 | $64.2M |
| jpmorgan chase & co | 3,460,215 | $58.3M |
| orbimed advisors llc | 2,806,811 | $50.2M |
| ubs group ag | 2,745,811 | $49.1M |
Showing top 10 of 198 institutional holders of Caris Life Sciences Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Caris Life Sciences Inc.'s pipeline?
Caris Life Sciences Inc. (CAI) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Caris Life Sciences Inc.'s lead drug candidate?
Caris Life Sciences Inc.'s most advanced tracked candidate is caris assure (Preclinical) for Minimal residual disease tracking and treatment monitoring.
What is Caris Life Sciences Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Caris Life Sciences Inc. has approximately 29.0 months of cash runway.
What is Caris Life Sciences Inc.'s market capitalization?
Caris Life Sciences Inc.'s market capitalization is approximately $5.1B.
Who is the CEO of Caris Life Sciences Inc.?
Dr. David Dean Halbert M.D. is the chief executive officer of Caris Life Sciences Inc. (CAI).
Get the full picture on Caris Life Sciences Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.